Researchers Identify Six Potential Biomarkers for Bipolar I Disorder

 

ROCHESTER, Minn. – Researchers have discovered a series of proteins that could be diagnostic markers to identify bipolar I disorder. If this discovery sample can be validated through replication, these markers may help as a diagnostic tool for psychiatrists treating mood disorders. The findings appear in Translational Psychiatry.

“The potential of having a biological test to help accurately diagnose bipolar disorder would make a huge difference to medical practice,” says Mark A. Frye, M.D., Psychiatry and Psychology chair at Mayo Clinic's campus in Rochester, Minnesota, and first author of the study. “It would then help clinicians to choose the most appropriate treatment for hard-to-diagnose individuals.”